FUNDAMENTALS · Fundamentals · MY Consumer Cyclical

InNature (5295) Fundamentals 2026 — P/E 34.0x, Revenue Analysis | SniperIQ

InNature (5295) is a MY-listed Consumer Cyclical company in Specialty Retail with a market capitalization of RM113M, trading at RM0.16 on the KLS. This SniperIQ fundamentals page covers InNature's valuation (P/E 34.0x, P/B 0.9x), profitability (net margin 2.2%), revenue (RM140M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapRM113M
P/E (TTM)34.0x
Net Margin2.2%
Revenue (FY25)RM140M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is InNature's market cap?

InNature (5295) has a market capitalization of approximately RM113M, trading at RM0.16 on the KLS. Market cap moves with the live share price.

What is InNature's P/E ratio?

InNature's trailing twelve-month P/E ratio is 34.0x, with a price-to-book (P/B) of 0.9x. Valuation multiples are best compared with Consumer Cyclical sector peers rather than read in isolation.

How profitable is InNature?

InNature runs a net profit margin of 2.2%, a gross margin of 32.4%, and an operating margin of 3.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does InNature generate?

InNature reported revenue of RM140M for fiscal year 2025, with net income of RM8M and earnings per share (EPS) of 0.0106. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does InNature pay a dividend?

InNature offers a trailing dividend yield of about 6.3%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is InNature financially healthy?

InNature carries a debt-to-equity ratio of 0.36x and a current ratio of 1.38x, with a market beta of 0.44. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is InNature a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For InNature (5295) the key facts are: market cap RM113M, P/E 34.0x, revenue RM140M, 52-week range 0.15-0.22. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Cyclical peers and form your own view.

Track InNature's full fundamentals live

Get InNature's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Medifast (MED) fundamentals · GreenTree Hospitality Group (GHG) fundamentals · Tilly's (TLYS) fundamentals · Taka Jewellery Holdings (42L) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons